15-03-2018
SACHS Biocapital USA Forum taking place on 21st March at the New York Academy of Sciences, USA. We are delighted to announce that CEO Lynn Durham will deliver a presentation showcasing STALICLA’s innovative approach and development pipeline, at 11:20am. In addition, Lynn will also be a part of the of the ‘Renewed Approaches for Neuroscience’ panel, which will be held at 11:45am. The Plenary panel is likely to be a highly anticipated session where Lynn will be discussing the hot topic of advanced therapeutics alongside other biotech and pharmaceutical leaders.
28-02-2018
STALICLA selected among the 2018 top 50 start-ups in Switzerland.
26-02-2018
STALICLA announced today that Lynn Durham, CEO and Founder, is scheduled to present at the 11th SACHS Associates 11th Annual Life Sciences CEO Forum being held February 26-27 in Zurich, Switzerland.
18-12-2017
STALICLA is proud to announce its selection on JPM UK Private Bank start-up ticket. Lynn Durham, CEO and Founder, is scheduled to present to the Healthcare Executive team during the 36th Annual JPM Healthcare conference, being held January 8-11, 2018 in San Francisco. Lynn’s presentation on the company’s strategy and development pipeline will take place on Tuesday 9th of January 2018 at 14:00 pm EST, 6th floor Westin St-Francis room.
24-11-2017
STALICLA is excited to announce a long-term research partnership with the Greenwood Genetic Center (GGC), a leading translational research center for neurodevelopmental disorders, including autism spectrum disorder (ASD).